分组1 - Community Health Systems reported quarterly earnings of $1.27 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.32 per share, representing an earnings surprise of +496.88% [1] - The company posted revenues of $3.09 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 3.22%, with year-ago revenues also at $3.09 billion [2] - The stock has added about 8% since the beginning of the year, underperforming the S&P 500's gain of 13.9% [3] 分组2 - The earnings outlook for Community Health Systems is mixed, with the current consensus EPS estimate for the coming quarter at $0.07 on $3.16 billion in revenues, and -$0.34 on $12.45 billion in revenues for the current fiscal year [7] - The Medical - Hospital industry, to which Community Health Systems belongs, is currently in the bottom 15% of the Zacks industries, indicating potential challenges ahead [8] - Universal Health Services, another company in the same industry, is expected to report quarterly earnings of $4.56 per share, reflecting a year-over-year change of +22.9% [9]

Group 1: Earnings Performance - Community Health Systems reported a quarterly loss of $0.05 per share, matching the Zacks Consensus Estimate, compared to a loss of $0.17 per share a year ago, indicating an earnings surprise of -200.00% [1] - The company posted revenues of $3.13 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.00%, although this represents a slight decline from year-ago revenues of $3.14 billion [2] - Over the last four quarters, Community Health Systems has surpassed consensus EPS estimates just once, but has topped consensus revenue estimates four times [2] Group 2: Stock Performance and Outlook - Community Health Systems shares have increased by approximately 28.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.3% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the upcoming quarter is -$0.24 on revenues of $2.97 billion, and -$0.31 on revenues of $12.32 billion for the current fiscal year [7] Group 3: Industry Context - The Medical - Hospital industry, to which Community Health Systems belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5] - The favorable estimate revisions trend prior to the earnings release has resulted in a Zacks Rank 2 (Buy) for Community Health Systems, indicating expected outperformance in the near future [6]

分组1 - Tenet Healthcare reported quarterly earnings of $4.02 per share, exceeding the Zacks Consensus Estimate of $2.84 per share, and showing an increase from $2.31 per share a year ago, resulting in an earnings surprise of +41.55% [1] - The company achieved revenues of $5.27 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.43%, and up from $5.1 billion year-over-year [2] - Tenet has outperformed the S&P 500 with a stock increase of about 38.4% since the beginning of the year, compared to the S&P 500's gain of 7.2% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $2.50 on revenues of $5.17 billion, and for the current fiscal year, it is $12.73 on revenues of $20.9 billion [7] - The Zacks Industry Rank indicates that the Medical - Hospital sector is in the bottom 28% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] 分组3 - Tenet has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] - The estimate revisions trend for Tenet was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market [6]

Core Viewpoint - Universal Health Services (UHS) shares have increased by approximately 12% over the past month, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Estimates Movement - Estimates for Universal Health Services have trended upward over the past month, indicating positive sentiment among analysts [2] VGM Scores - Universal Health Services currently holds a strong Growth Score of A, a Momentum Score of B, and a Value Score of A, placing it in the top 20% for the value investment strategy, resulting in an aggregate VGM Score of A [3] Outlook - The upward trend in estimates suggests a promising outlook for Universal Health Services, which currently has a Zacks Rank of 3 (Hold), indicating expectations for an in-line return in the coming months [4] Industry Performance - Universal Health Services is part of the Zacks Medical - Hospital industry, where HCA Healthcare has gained 11.2% over the past month, reporting revenues of $18.32 billion for the last quarter, reflecting a year-over-year increase of 5.7% [5] - HCA is projected to report earnings of $6.20 per share for the current quarter, representing a year-over-year change of 12.7%, with the Zacks Consensus Estimate remaining unchanged over the last 30 days, also holding a Zacks Rank of 3 (Hold) and a VGM Score of A [6]

Group 1 - HCA Healthcare reported quarterly earnings of $6.45 per share, exceeding the Zacks Consensus Estimate of $5.77 per share, and up from $5.36 per share a year ago, representing an earnings surprise of 11.79% [1] - The company posted revenues of $18.32 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.08%, and an increase from $17.34 billion year-over-year [2] - HCA shares have increased approximately 13.8% since the beginning of the year, contrasting with the S&P 500's decline of -6.8% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $6.18 on revenues of $18.45 billion, and for the current fiscal year, it is $24.98 on revenues of $74.69 billion [7] - The Medical - Hospital industry, to which HCA belongs, is currently ranked in the top 10% of over 250 Zacks industries, indicating strong performance potential [8] Group 3 - HCA has surpassed consensus EPS estimates in all four of the last quarters, indicating consistent performance [2] - The estimate revisions trend for HCA is currently mixed, resulting in a Zacks Rank 3 (Hold) for the stock, suggesting it is expected to perform in line with the market in the near future [6]